We have previously shown the high effectiveness of GC7 pretreatment, a specific and reversible eIF5A hypusination inhibitor, in protecting the kidney from ischemia situations and proximal convoluted tubule cells (PCT) from anoxia [41]. This evidence concerns the gene EIF5A and ischemia.